Submitted by Anonymous (not verified) on 19 September 2024 - 13:40
Opinion/decision on a Paediatric investigation plan (PIP): Dupixent, dupilumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0541/2022
Source: